Expert Perspectives From AUA 2025: Contextualizing the Evolving Landscape of Bladder Cancer
Neal Shore, MD, FACS
Sarah Psutka, MD, MS
Acromegaly Care: Individualized Diagnosis and Management Strategies
July 13, 2025
San Francisco, California
New Strategies for Individualizing Treatment in DME
Luis A. Gonzalez, MD, MPH
Jeremiah Brown Jr., MD, MS, FASRS
Trial in Progress: Phase 3 MoonRISe-3 Study
Treatment Advances in Generalized Myasthenia Gravis: A Pathophysiology-Driven Framework Leveraging FcRn Therapeutics
Vera Bril, MD
Neelam Goyal, MD
Preventing Myasthenic Crisis: Early Signs and Critical Interventions
Hans Katzberg, MD
Treatment Advances in Generalized Myasthenia Gravis: Addressing the Nuances of its Underlying Immunopathology
Nicholas J. Silvestri, MD
Managing Side Effects in FcRn Therapy: Best Practices for gMG
Treatment Advances in Generalized Myasthenia Gravis: Clinical and Laboratory Criteria for Diagnosis and Optimal Treatment Selection
Jonathan Strober, MD
A Scientific Look at FcRn Antagonists: Mechanisms of Action Explained
Living with gMG: Navigating Personal, Professional, and Mental Health Challenges
Traditional MG Treatments: Balancing Benefits, Risks, and Side Effect Management
New Frontiers in MG: How FcRn Antagonists Are Changing MG Therapy
What’s New in Subconjunctival MIBS
Paul Petrakos, DO, MS
I. Paul Singh, MD
What’s New in Glaucoma Therapy?
Justin Schweitzer, OD, FAAO
Sarah H. Van Tassel, MD
What’s New in Glaucoma Topical Therapies?
Loading...
We're glad to see you're enjoying Prova Education… but how about a more personalized experience?
Press cancel to remain on Prova Education. Press the link below or the continue button to keep going.